pulmonary nodule
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Age between 18-80 years old (inclusive), gender not restricted; 2: Ground-glass or part-solid lung nodules =3cm in diameter, either solitary or multiple. 3: Subjects without major organ dysfunction, with normal blood routine, liver, kidney, and heart function tests. 4: Patients have signed the informed consent form, voluntarily accepting treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1: Malignant tumors that have not reached clinical cure and still require adjuvant therapy or palliative treatment; 2: Recent lung disease due to rheumatic immune disorders; presence of obstructive pneumonia, atelectasis, hilar enlargement, or pleural effusion; patients with hemoptysis or blood-tinged sputum, and patients with tuberculosis; 3: Pregnant or breastfeeding women; 4: Individuals with severe primary heart, liver, lung, kidney, blood diseases, or other serious illnesses affecting survival; patients with mental disorders or altered consciousness; 5: Those allergic to or intolerant of Chinese herbs and/or known components of the "Yiqi Chutan Formula"; 6: Individuals unable to comply with follow-up requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease control rate (DCR, disease control rate) for pulmonary nodules based on the RECIST; | — |
Secondary
| Measure | Time frame |
|---|---|
| Malignant risk assessment based on AI malignancy risk model;Evaluation of Traditional Chinese Medicine (TCM) symptom efficacy (TCM constitution symptom score and TCM symptom score);Satisfaction score; | — |
Countries
China
Contacts
The First Affiliated Hospital of Guangzhou University of Chinese Medicine